Precigen, Inc.
PGEN
$3.71
$0.143.92%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1,633.93% | 281.35% | 206.93% | 16.76% | 26.87% |
| Total Other Revenue | -- | -159.09% | -- | 161.54% | 187.50% |
| Total Revenue | 1,633.93% | 283.61% | 206.61% | 19.39% | 25.92% |
| Cost of Revenue | -29.20% | -33.58% | 8.34% | -19.60% | -24.45% |
| Gross Profit | 247.06% | 65.74% | 8.19% | 42.56% | 28.21% |
| SG&A Expenses | 70.31% | 60.41% | 143.91% | 56.54% | 21.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.18% | 9.63% | 68.37% | 6.29% | -6.04% |
| Operating Income | 73.47% | 4.71% | -62.17% | -5.94% | 7.43% |
| Income Before Tax | 85.36% | -18.62% | -510.63% | 55.95% | -127.85% |
| Income Tax Expenses | -- | 100.00% | -- | 100.18% | -- |
| Earnings from Continuing Operations | 85.36% | -19.14% | -510.33% | 54.68% | -128.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 85.36% | -19.14% | -510.33% | 54.68% | -128.13% |
| EBIT | 73.47% | 4.71% | -62.17% | -5.94% | 7.43% |
| EBITDA | 77.72% | 7.01% | -63.58% | -10.23% | 3.72% |
| EPS Basic | 87.85% | 1.49% | -1,118.87% | 61.42% | -93.59% |
| Normalized Basic EPS | 87.85% | 13.54% | -448.43% | 25.39% | -93.29% |
| EPS Diluted | 87.85% | 1.49% | -1,118.87% | 61.42% | -93.59% |
| Normalized Diluted EPS | 87.85% | 13.54% | -448.43% | 25.39% | -93.29% |
| Average Basic Shares Outstanding | 20.56% | 20.86% | 11.34% | 17.46% | 17.92% |
| Average Diluted Shares Outstanding | 20.56% | 20.86% | 11.34% | 17.46% | 17.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |